Most Americans say that the flu shot is the best preventive measure, but only a lot will get it

Fall is here, meaning cooler weather, changing leaves, and pumpkin spice lattes are ahead. But the new season also brings seasonal flu, which corresponds to the ongoing coronovirus crisis this year.

As COVID-19 continues to devastate the country, more than 200,000 American lives have been claimed by the novel virus, with health experts inundating hospital systems with both coronary and flu patients from the public Urging to get the flu vaccine in an effort to save.

But the results of a survey conducted by the National Foundation for Infectious Diseases (NFID) and conducted by NORC at the University of Chicago were provided to Fox News before being released on Thursday, while most participants agreed to the vaccine Has The best protection against the flu, is a small percentage plan to actually vaccinate.

In a survey of 1,000 adults 18 or older nationwide, 68% agreed that receiving the flu vaccine

In a survey of 1,000 adults 18 or older nationwide, 68% agreed that getting the flu vaccine was “the best preventive measure against flu-related deaths and hospitals”, compared with 61% previously Was above the year. (IStock)

In a survey of 1,000 adults 18 or older nationwide, 68% agreed that getting the flu vaccine was “the best preventive measure against flu-related deaths and hospitals”, compared with 61% previously Was above the year.

Can you get a flu shot? 2020-21 to know about FLU SEASON

But by comparison, only 59% of respondents said they actually plan to vaccinate against the flu, with 15% saying they are unsure. (For reference, in 2019, 52% of respondents said they planned to receive the flu vaccine that year.)

Of those who are unsure, some 34% said they do not think flu vaccines work well – a significant decrease from 2019, with 51% of respondents reporting the same – while 32% said they did not “have the flu Get.” Another 29% said they were concerned about the potential side effects of the vaccine, while some 22% said they were concerned about getting the flu from the vaccine (note: low-grade fever in flu shot reactions or Muscle pain may be involved., But the vaccine cannot cause the flu virus). Additionally, some 17% of respondents said they are unsure about getting a flu shot because they are “concerned about the potential risk of COVID-19 if they go out to vaccinate.”

Concerningly, approximately one in four respondents (22%) who are considered high-risk for flu-related complications – 65 years of age or older in high-risk groups, smokers as well as diabetes , People with asthma, heart disease. Or kidney disease – do not plan to get a flu vaccine this year.

About 60% of White respondents plan to receive the vaccine, while 65% of Hispanics have said the same. But about 64% of black respondents said they do not plan to get a flu shot or are unsure if they will.

For flu season occurring with COVID-19, the majority of the adults surveyed said they were more concerned about contracting the coronovirus than the flu, with 46% saying they were COVID. -19 are very concerned about infection (in themselves or someone) their family). “Only 23% reported the same for the flu.

“46% are worried about being infected with COVID-19 and the flu at the same time,” according to the survey, with Black respondents being the most concerned about it, at 61%, 53% of Hispanics and whites. Compared to 39%.

Former women find out that they are isolated from the waist, CDC sass.

Overall, however, 28% said the epidemic made them more likely to be vaccinated against the flu this year.

As for taking antiviral drugs to reduce flu symptoms, the “overwhelming majority” said they would do so with 77% of respondents, according to the survey.

Interestingly, black adults surveyed were more likely to have no flu antivirals (39%) than whites and Hispanic (22% and 17%, respectively).

Respondents were also asked about their knowledge surrounding pneumococcal disease, “which is caused by bacteria and according to the survey can cause a variety of diseases including pneumonia, meningitis, ear and sinus infections and sepsis.”

An estimated 46% said they were not familiar with the disease, which was unchanged from 2019, while 51% said they were “advised not to be vaccinated against pneumococcal disease.”

Some 65% of respondents said they were unsure of their pneumococcal vaccination status or said they had not received it, while 89% had not vaccinated it, saying they were either unsure or vaccinated. Were not planning to receive.

28% said they did not plan to receive the pneumococcal vaccine or were unsure if they, too, would report concern about potential side effects from the vaccine, while 15% said they would be concerned about the potential risk of COVID-19. I was worried if he left his house to vaccinate.

Can you see friends and family before getting a coronary test?

“These survey findings highlight the importance of addressing misconceptions about flu and pneumococcal vaccine safety and effectiveness, especially in the context of the COVID-19 epidemic,” NFID officials said in the survey, “in contrast to COIDID-19, Are currently safe. ” Effective vaccines available in the US to help prevent flu and pneumococcal disease.

“Now more than ever, during the COVID-19 pandemic, flu vaccination protects not only for ourselves, our loved ones and our community (especially those who are most vulnerable to children, adults age 65+) and some chronic be important for. Health conditions) but to reduce potential stress on the American health system, ”he continued. “Even in cases when flu vaccination does not completely prevent infection, it can reduce the severity and duration of the disease and prevent serious complications.

“The survey’s findings underscore the need to address health disparities and educate populations at increased risk, including older adults and individuals with chronic health conditions such as lung disease, heart disease, and diabetes, who have the flu. And COVID are at high risk for complications from both. 19, “he concluded.

Leave a Reply

Your email address will not be published.